Washington University Researchers Identify Novel Compound G2 as Potent Autophagy Booster to Clear Toxic Tau Proteins in Frontotemporal Dementia

WashU Medicine researchers find that compound G2 restores cellular clean-up systems to clear toxic tau proteins, offering a new path for dementia treatment.

By: AXL Media

Published: Apr 1, 2026, 9:08 AM EDT

Source: Information for this report was sourced from WashU Medicine

Restoring the Cellular Waste Management System

The biological deterioration seen in neurodegenerative diseases is often driven by the failure of brain cells to eliminate their own cellular waste. New research from Washington University School of Medicine in St. Louis suggests that enhancing a process called autophagy—the body’s natural mechanism for recycling damaged proteins—could be a transformative treatment strategy. As humans age, the efficiency of this cellular clean-up system naturally declines, leading to a toxic buildup of "molecular garbage." By utilizing a novel compound to jumpstart this process, scientists have successfully cleared harmful proteins from neurons modeling frontotemporal dementia, effectively making the diseased cells appear and function like healthy ones.

The Impact of Misfolded Tau on Neuronal Health

Frontotemporal dementia is a devastating condition that often strikes in middle age, characterized by dramatic shifts in personality and behavior before cognitive decline begins. The disease is primarily driven by mutations in the tau protein, which cause it to misfold and aggregate inside the brain’s nerve cells. Professor Celeste Karch and her team discovered that these specific tau mutations essentially "clog" the cell’s internal recycling centers, known as lysosomes. When these lysosomes become dysfunctional, cellular waste accumulates to lethal levels, eventually triggering the widespread neuronal death that defines the progression of dementia.

The Versatile Protective Effects of Compound G2

The focus of the study was a chemical analog of G2, a compound originally discovered in 2019 for its ability to treat liver disease. Researchers found that G2 possesses an impressive ability to boost autophagy across multiple types of cellular dysfunction. Beyond its success in clearing tau proteins, previous experiments at WashU Medicine have shown that G2 can protect cells from Huntington’s disease by preventing the buildup of harmful RNA molecules. This suggests that the compound may serve as a universal "molecular janitor," capable of protecting brain cells regardless of which specific toxic protein is causing the blockage.